Navigation Links
Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™
Date:3/28/2012

EMERYVILLE, Calif., March 28, 2012 /PRNewswire/ -- Bionovo, Inc. (OTCQB: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today that the Company's independent Data Safety Monitoring Board (DSMB) recommended that the Phase 3 trial of Menerba (MF101) could continue as designed after an initial review of its clinical safety and tolerability data. Menerba is Bionovo's oral botanical drug candidate designed for the safe and effective treatment of vasomotor symptoms (hot flashes) associated with menopause.

The DSMB evaluated unblinded safety and dose tolerability data after 66 participants were randomized and on study medication for at least 30 days.  After an independent review of the data, the DSMB issued their positive recommendation to continue the trial as originally designed and no concerning safety signals were identified.

"I am very encouraged by the positive recommendation from our independent DSMB. This assurance that Menerba™ continues to be a safe, well-tolerated, non-estrogen alternative therapy for the treatment of menopausal hot flashes is consistent with the promising results of our early clinical trial data and extensive pre-clinical toxicity studies. We are very eager to continue to develop a safe and effective treatment for post-menopausal hot flashes, a drug that can be the leading seller in the well established multibillion dollar market," said Mary Tagliaferri, M.D., Bionovo's President and Chief Medical Officer.  

The MF101-004 Phase 3 pivotal study dosed its first patient on November 16, 2011. To date, a total of 280 postmenopausal women have been randomized to the trial. Recruitment to the Phase 3 trial was voluntarily halted on March 9, 2012 as Bionovo does not have adequate funding to further advance the registration trial. Bionovo will need to secure additional financing to complete either a
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Halo Therapeutics Reports Favorable Independent Review of Lead Drug Candidate HT-100
2. New Survey: Walgreens Customers Flock to Independent Pharmacies
3. EPS Security to Add "Medical Alert" Services for Independent Seniors
4. Independent Data Published on BioLife Solutions HypoThermosol® and CryoStor®
5. Aria Announces Publication of Independent Study in the American Journal of Obstetrics & Gynecology Using Arias Technology
6. Parata Systems Announces Presenting Sponsorship of 2012 Independent Pharmacy Business Growth Conference
7. Winner Medical Appoints BDO China as Independent Auditor
8. NCPA Launches Initiative to Help Independent Community Pharmacies Create Better Business Opportunities for Front-End Merchandise
9. Independent Laboratory Testing Demonstrates Important Quality Differences Between FDA-Approved Makena® and Compounded 17P Formulations
10. Adeona Appoints Jeff Lucero Riley as Independent Chairman
11. NCPA Digest Finds Independent Community Pharmacies Reducing Health Costs Through Generic Drug Use, Patient Counseling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ... the "Dental Consumables Market - Global Industry ... - 2018" report to their offering. ... ) Dental consumables are products which are ... impairments, for tooth restoration and in treatment of ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading ... company, awarded several new IT value-added reseller (VAR) ... hospital organizations with IT goods and services at ... agreements, as well as value-added services such as ... New Novation agreements were awarded to ...
(Date:1/15/2014)... DUBLIN , January 15, 2014 ... that it has waived the Office of Fair Trading (OFT) ... the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).   ... no longer conditional on OFT approval, and Shire expects to ... currently scheduled expiration time, subject to the satisfaction of all ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... BEIJING , May 14 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems ... marketing and,sale of medical products in China , today reported ... . , (Logo: http://www.newscom.com/cgi-bin/prnh/20100422/CNTH001LOGO ), ... for the first quarter ended March 31, 2010 increased 5% to, ...
... BEIJING , May 14 /PRNewswire-Asia-FirstCall/ -- ... growing developer,manufacturer and seller of medicine and drugs in the ... for the first quarter,ended March 31, 2010 . , , ... -- Diluted EPS of $0.09, up 27% from first ...
Cached Medicine Technology:Dehaier Medical Systems Announces First Quarter Net Income Up 54% 2Dehaier Medical Systems Announces First Quarter Net Income Up 54% 3Dehaier Medical Systems Announces First Quarter Net Income Up 54% 4Dehaier Medical Systems Announces First Quarter Net Income Up 54% 5Dehaier Medical Systems Announces First Quarter Net Income Up 54% 6Dehaier Medical Systems Announces First Quarter Net Income Up 54% 7Dehaier Medical Systems Announces First Quarter Net Income Up 54% 8Dehaier Medical Systems Announces First Quarter Net Income Up 54% 9Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results 2Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results 3Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results 4Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results 5Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results 6Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results 7Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results 8Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results 9Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results 10
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... Pharmaceuticals,Inc. (Nasdaq: CADX ), a biopharmaceutical company ... principally,for use in the hospital setting, today announced ... before the market opens on Tuesday, May 6,2008., ... and live webcast to,discuss the financial results and ...
... to Both Reduce Exacerbations ... and Improve Lung Function, ... and Drug Administration today approved Advair Diskus(R) 250/50,(fluticasone propionate 250 ... exacerbations in patients with chronic obstructive,pulmonary disease (COPD) who have ...
... Phase of NHLBI-Sponsored Study on Children,s Physical Activity in Child Care ... at Pediatric Academic Societies ... Annual Meeting, CINCINNATI, ... 3-6) are in child care centers, and growing concern over,childhood obesity has ...
... prolapse a tear or weakness in a womans pelvic ... the body runs in families, a new Saint Louis ... has had a hernia or prolapse two conditions that ... more likely to develop prolapse themselves, says Mary McLennan, M.D., ...
... April 30 NightHawk,Radiology Holdings, Inc. (Nasdaq: ... radiology groups and hospitals throughout the United States,today ... appointed as an,independent member of the company,s Board ... change, the company has regained compliance with the ...
... FOREST, Ill., April 30 Hospira, Inc.,(NYSE: HSP ... announced that Thomas E. Werner, senior vice president,Finance, and ... Bank of America 2008 Health Care Conference on Wednesday, ... Vegas., The presentation is scheduled to begin at ...
Cached Medicine News:Health News:Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 2Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 3Health News:FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD 4Health News:Flip Flops, Mulch and No Coat: Study Identifies Surprising Barriers to Outdoor Activity for Kids in Child-Care Centers 2Health News:Flip Flops, Mulch and No Coat: Study Identifies Surprising Barriers to Outdoor Activity for Kids in Child-Care Centers 3Health News:Flip Flops, Mulch and No Coat: Study Identifies Surprising Barriers to Outdoor Activity for Kids in Child-Care Centers 4Health News:Family history places women at risk of pelvic organ prolapse, SLU research finds 2Health News:NightHawk Radiology Holdings, Inc. Announces Appointment of David Engert to the Board of Directors 2Health News:NightHawk Radiology Holdings, Inc. Announces Appointment of David Engert to the Board of Directors 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: